Dr. Ramaswamy Govindan, MD

  • Saint Louis, MO
  • Medical oncologist
NPI1023034261PAC ID6103812185
Medicare services, 2024
6,149
Medicare patients, 2024
246
Part D claims, 2024
680
Clinical trials
1
MIPS score, 2024
84
Practice address
One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110
Practice phone
Call (314) 747-3000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Barnes-Jewish Hospital

Hospital · Saint Louis, Missouri

See all 5 affiliations

Find Dr. Govindan's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Ramaswamy Govindan is a medical oncologist in Saint Louis, Missouri

Dr. Govindan practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Govindan's NPI, 1023034261, was assigned on July 14, 2006. Dr. Govindan holds Missouri license 103872.

NPI and contact details
Medicare PAC ID
6103812185
NPI enumeration date
July 14, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(314) 747-3000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
66
Medical school graduation
1986

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Ramaswamy Govindan practices at 2 locations in Saint Louis, Missouri

Dr. Govindan's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Govindan also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

  • Barnes-Jewish HospitalPrimary
    One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 · St. Louis CityPhone(314) 747-3000
  • Barnes-Jewish Hospital
    1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 · Saint Louis CityPhone(314) 747-3000

Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; and Dmand AI Practice Data

Dr. Ramaswamy Govindan is affiliated with 4 sites of care and 1 medical group

Dr. Govindan's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Govindan is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Govindan to 1 more hospital and 1 group practice or clinic, each named with a free account.

See all 5 affiliations for Dr. Govindan

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Ramaswamy Govindan's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Govindan practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Barnes-Jewish HospitalAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Govindan practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across BJC Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Ramaswamy Govindan is one of 120 medical oncologists in Missouri

Medical oncology is Dr. Govindan's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Govindan is licensed in Missouri.

Specialties and state licenses

  • Medical oncology, MissouriPrimaryLicense 103872 · taxonomy 207RX0202X

Medical oncologists near Dr. Govindan

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Ramaswamy Govindan billed Medicare for 6,149 services in 2024

CMS data shows 6,149 Medicare services from Dr. Govindan across 20 procedure codes in 2024, for 246 Medicare patients. Medicare paid $235,431 for them.

Medicare services, 20246,149
Medicare patients246
Paid by Medicare$235,431
Procedure codes20

Dr. Govindan's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 28,0922024: 5,41281%
Tests and treatments
2023: 1,2402024: 43765%
Office and hospital visits
2023: 2472024: 21712%
Surgery
2023: 2592024: 8368%
Other services
2023: 2,0132024: 0100%

Where Dr. Govindan's Medicare services took place, 2024

  • In an office6,138100%
  • In a facility110%

Dr. Govindan compared with the Missouri median for medical oncologists, 2024

  • Dr. Govindan
  • Missouri median
Medicare services
6,149vs 1,2464.9 times
Medicare patients
246vs 22410% above
Part D claims
551vs 560Close to median

Medians across 125 medical oncologists in Missouri with Dmand AI profiles that report each measure.

Dr. Govindan's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Govindan

Need commercial claims for Dr. Govindan?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Govindan and other medical oncologists in Missouri.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Ramaswamy Govindan treated 246 Medicare patients in 2024, average age 72

CMS counts 246 Medicare patients who saw Dr. Govindan in 2024. The largest group is 65 to 74, with 125 patients. 70% of them have high cholesterol, and 67% have high blood pressure. 11% are also on Medicaid. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Govindan's median patient age at 72, with 68% women.

Medicare patients, 2024246
Average age72
Average risk score2.76
Also on Medicaid11%

Dr. Govindan's Medicare patients by age, 2024

Dr. Govindan's Medicare patients by sex, 2024

  • Women12651%
  • Men12049%

Chronic conditions among Dr. Govindan's Medicare patients, 2024

  1. High cholesterol70%
  2. High blood pressure67%
  3. Cancer63%
  4. Arthritis39%
  5. Ischemic heart disease33%
  6. Anxiety30%
  7. Diabetes28%
  8. COPD27%

Share of Medicare patients with each condition. A patient can have several.

Dr. Govindan's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women68%
  • Men32%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Ramaswamy Govindan wrote 680 Medicare Part D claims in 2024

In 2024, Dr. Govindan wrote 680 Medicare Part D claims for 76 patients. 74% of them were for generic drugs. CMS names the drug for 551 of them, across 25 drugs with 11 or more claims each, at $741,630 in total drug cost. In 2023, CMS named 396 claims across 18 drugs.

Part D claims, 2024680
Drugs named by CMS25
Total drug cost$741,630
Part D patients76

Dr. Govindan's Part D claims by kind of drug, 2024

  • Generic501 claims74%
  • Brand-name179 claims26%

Dr. Govindan's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Govindan's Part D claims, 2024

  • Opioids12%82 of 680 claims
  • Antibiotics2%15 of 680 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3962024: 55139%

Drugs named by CMS: 25 in 2024, 18 in 2023.

See all prescribing by Dr. Govindan

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Ramaswamy Govindan scored 84 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Govindan for performance year 2024, reported as part of a group. Dr. Govindan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Govindan's MIPS scores, performance year 2024

  • 84of 100Final score
  • 71.6of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 76of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Govindan by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Ramaswamy Govindan has worked on 1 clinical trial

Dmand AI links Dr. Govindan to 1 clinical trial. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic. Open Payments lists research payments to Dr. Govindan that name 1 trial.

Conditions in Dr. Govindan's trials

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Bronchogenic

Investigators on the most trials with Dr. Govindan

Recent clinical trials with Dr. Govindan

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage

Dr. Ramaswamy Govindan received $111,892 in industry payments from 2016 to 2024

CMS Open Payments shows 130 general payments to Dr. Govindan from 21 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 70% of the total. Genentech, Inc. paid the most, $31,356. It also lists 29 research payments totaling $89,004 from 2016 to 2025, naming 1 clinical trial.

General payments to Dr. Govindan by program year, 2016 to 2024

General payments to Dr. Govindan by kind, 2016 to 2024

$111.9Kin total
  • Consulting fees$78,13270%
  • Travel and lodging$24,98222%
  • Speaker and faculty fees$3,7203%
  • Food and beverage$3,5333%
  • Education$1,5241%

Companies that paid Dr. Govindan the most, 2016 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Govindan

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Ramaswamy Govindan's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDmand AI Practice Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Clinical trials and co-investigatorsClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Ramaswamy Govindan

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Ramaswamy Govindan's NPI number?

Dr. Ramaswamy Govindan's NPI number is 1023034261. It was assigned on July 14, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Ramaswamy Govindan?

Dr. Ramaswamy Govindan is a medical oncologist in Saint Louis, Missouri. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Ramaswamy Govindan practice?

Dr. Govindan practices at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110. Dr. Govindan also practices at 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110. Dr. Govindan's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dmand AI also links Dr. Govindan to 1 hospital and 1 group practice or clinic.

What is Dr. Ramaswamy Govindan's office phone number?

The practice phone on file for Dr. Govindan is (314) 747-3000.

What is Dr. Ramaswamy Govindan's medical license number?

Dr. Govindan holds Missouri license 103872.

Which hospitals is Dr. Ramaswamy Govindan affiliated with?

Dr. Govindan practices at Barnes-Jewish Hospital in Saint Louis, Missouri. Dr. Govindan is also affiliated with Missouri Baptist Medical Center. Dmand AI links Dr. Govindan to 1 more hospital.

What medical group is Dr. Ramaswamy Govindan part of?

Dr. Govindan is linked to WashU Medicine Psychiatry.

Does Dr. Ramaswamy Govindan accept Medicare?

Yes. CMS data shows Dr. Govindan billed Medicare for 6,149 services in 2024, and Dr. Govindan accepts Medicare assignment.

What is Dr. Ramaswamy Govindan's MIPS score?

Dr. Govindan's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.

How many Medicare patients does Dr. Ramaswamy Govindan see?

CMS counts 246 Medicare patients who saw Dr. Govindan in 2024, with an average age of 72.

Show 5 more questionsShow fewer questions

What services does Dr. Ramaswamy Govindan bill to Medicare?

In 2024, Dr. Govindan's most billed Medicare services were injected or infused drug (J9271), injected or infused drug (J1100) and injected or infused drug (J2469).

What drugs does Dr. Ramaswamy Govindan prescribe most?

In 2024 Medicare Part D data, Dr. Govindan's most prescribed drugs by claims were Dexamethasone, Eliquis and Prochlorperazine Maleate.

Has Dr. Ramaswamy Govindan received payments from drug or device companies?

CMS Open Payments shows $111,892 in general payments to Dr. Govindan from 21 companies from 2016 to 2024. The largest total came from Genentech, Inc.

How long has Dr. Ramaswamy Govindan been practicing?

Dr. Govindan graduated from medical school in 1986, 40 years ago.

Does Dr. Ramaswamy Govindan do research?

Dr. Govindan has worked on 1 clinical trial.

Selling to medical oncology practices?

See medical oncologists in Missouri by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)